Evidence map›Paper›PMID 24752060›Full record

ArticleJournal of clinical oncology : official journal of the American Society of Clinical Oncology2014

Reply to M.C. Chamberlain.

Mark R Gilbert, James Dignam, Stephanie Pugh, Terri S Armstrong, Jeffrey S Wefel, Ken Aldape, Roger Stupp, Monika Hegi, Minhee Won, Walter J Curran and 1 more

Abstract readLetterComment
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors.

Mark R GilbertThe University of Texas MD Anderson Cancer Center, Houston, TX mrgilbert@mdanderson.org.
James DignamRadiation Therapy Oncology Group Statistical Center, Philadelphia, PA.
Stephanie PughRadiation Therapy Oncology Group Statistical Center, Philadelphia, PA.
Terri S ArmstrongThe University of Texas MD Anderson Cancer Center; The University of Texas Health Science Center-School of Nursing, Houston, TX.
Jeffrey S WefelThe University of Texas MD Anderson Cancer Center, Houston, TX.
Ken AldapeThe University of Texas MD Anderson Cancer Center, Houston, TX.
Roger StuppUniversity Hospital Zurich, Zurich, Switzerland.
Monika HegiLausanne University Hospitals, Lausanne, Switzerland.
Minhee WonRadiation Therapy Oncology Group Statistical Center, Philadelphia, PA.
Walter J CurranEmory University Winship Cancer Center, Atlanta, GA.
Minesh P MehtaUniversity of Maryland, Baltimore, MD.

Funding

RTOG Foreign AccrualU10CA021661 · NCI · AMERICAN COLLEGE OF RADIOLOGY · PI CURRAN, WALTER J. · 1985 to 2013
$150.3M
RTOG Foreign AccrualsU10CA037422 · NCI · AMERICAN COLLEGE OF RADIOLOGY · PI BRUNER, DEBORAH WATKINS · 1985 to 2013
$30.4M
NCI NIH HHS U10 CA021661NCI NIH HHS U10 CA037422
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Antineoplastic Agents, AlkylatingBrain NeoplasmsDacarbazineFemaleGlioblastomaHumansMaleAntineoplastic Agents, AlkylatingDacarbazine

Identifiers

PMID24752060
PMCPMC4026583

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.